Proteome Sciences plc
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in pla… Read more
Proteome Sciences plc - Asset Resilience Ratio
Proteome Sciences plc (PMSNF) has an Asset Resilience Ratio of 0.00% as of June 2019. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2001–2018)
This chart shows how Proteome Sciences plc's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Proteome Sciences plc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $0.00 | 0% |
| Total Liquid Assets | $0.00 | 0.00% |
Asset Resilience Insights
- Limited Liquidity: Proteome Sciences plc maintains only 0.00% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company maintains a balanced mix of cash and short-term investments.
Proteome Sciences plc Industry Peers by Asset Resilience Ratio
Compare Proteome Sciences plc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
ADCNF
OTCGREY:ADCNF |
Diagnostics & Research | 1.12% |
|
Berry Genomics Co Ltd
SHE:000710 |
Diagnostics & Research | 0.45% |
|
NSN Co. Ltd
KQ:031860 |
Diagnostics & Research | 1.72% |
|
JOONGANG DNM Co.Ltd
KQ:051980 |
Diagnostics & Research | 27.26% |
|
GeneMatrix Inc
KQ:109820 |
Diagnostics & Research | 41.52% |
|
Genoray Co. Ltd
KQ:122310 |
Diagnostics & Research | 0.03% |
|
Green Cross Lab Cell Corporation
KQ:144510 |
Diagnostics & Research | 0.18% |
|
Optipharm.CO.LTD
KQ:153710 |
Diagnostics & Research | 20.73% |
Annual Asset Resilience Ratio for Proteome Sciences plc (2001–2018)
The table below shows the annual Asset Resilience Ratio data for Proteome Sciences plc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2018-12-31 | 0.00% | $0.00 | $7.03 Million | -- |
| 2017-12-31 | 0.00% | $0.00 | $7.48 Million | -- |
| 2016-12-31 | 0.00% | $0.00 | $9.70 Million | -- |
| 2015-12-31 | 0.00% | $0.00 | $8.73 Million | -- |
| 2014-12-31 | 0.00% | $0.00 | $8.29 Million | -- |
| 2005-12-31 | 19.84% | $1.90 Million | $9.57 Million | +2.44pp |
| 2004-12-31 | 17.40% | $1.80 Million | $10.34 Million | -15.83pp |
| 2003-12-31 | 33.24% | $4.79 Million | $14.43 Million | +9.01pp |
| 2002-12-31 | 24.23% | $3.35 Million | $13.83 Million | +18.22pp |
| 2001-12-31 | 6.00% | $225.00K | $3.75 Million | -- |